ArticleInternational journal of hematology2013

Tumor lysis syndrome soon after treatment with hydroxyurea followed by nilotinib in two patients with chronic-phase chronic myelogenous leukemia.

Jian Hua et al.PubMed ↗Publisher ↗

No numbers read from the abstract.